J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

NSE:JBCHEPHARM Revenue

J. B. Chemicals & Pharmaceuticals had revenue of 10.65B INR in the quarter ending December 31, 2025, with 10.51% growth. This brings the company's revenue in the last twelve months to 41.93B, up 9.47% year-over-year. In the fiscal year ending March 31, 2025, J. B. Chemicals & Pharmaceuticals had annual revenue of 39.18B with 12.45% growth.

• Revenue (ttm): 41.93B
• Revenue Growth: +9.47%
• P/S Ratio: 8.18
• Revenue / Employee: 7.91M
• Employees: 5,304
• Market Cap: 343.14B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	39.18B	4.34B	12.45%
Mar 31, 2024	34.84B	3.35B	10.63%
Mar 31, 2023	31.49B	7.25B	29.91%
Mar 31, 2022	24.24B	3.82B	18.69%
Mar 31, 2021	20.43B	2.68B	15.09%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error